1. Home
  2. OVID vs KPLT Comparison

OVID vs KPLT Comparison

Compare OVID & KPLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OVID
  • KPLT
  • Stock Information
  • Founded
  • OVID 2014
  • KPLT 2012
  • Country
  • OVID United States
  • KPLT United States
  • Employees
  • OVID N/A
  • KPLT N/A
  • Industry
  • OVID Biotechnology: Pharmaceutical Preparations
  • KPLT Diversified Commercial Services
  • Sector
  • OVID Health Care
  • KPLT Consumer Discretionary
  • Exchange
  • OVID Nasdaq
  • KPLT Nasdaq
  • Market Cap
  • OVID 47.1M
  • KPLT 46.2M
  • IPO Year
  • OVID 2017
  • KPLT N/A
  • Fundamental
  • Price
  • OVID $0.45
  • KPLT $11.06
  • Analyst Decision
  • OVID Strong Buy
  • KPLT Hold
  • Analyst Count
  • OVID 6
  • KPLT 2
  • Target Price
  • OVID $3.20
  • KPLT $12.00
  • AVG Volume (30 Days)
  • OVID 312.2K
  • KPLT 17.6K
  • Earning Date
  • OVID 03-11-2025
  • KPLT 03-28-2025
  • Dividend Yield
  • OVID N/A
  • KPLT N/A
  • EPS Growth
  • OVID N/A
  • KPLT N/A
  • EPS
  • OVID N/A
  • KPLT N/A
  • Revenue
  • OVID $566,000.00
  • KPLT $241,789,000.00
  • Revenue This Year
  • OVID N/A
  • KPLT $13.38
  • Revenue Next Year
  • OVID N/A
  • KPLT $7.29
  • P/E Ratio
  • OVID N/A
  • KPLT N/A
  • Revenue Growth
  • OVID 44.50
  • KPLT 14.99
  • 52 Week Low
  • OVID $0.46
  • KPLT $5.08
  • 52 Week High
  • OVID $3.45
  • KPLT $23.54
  • Technical
  • Relative Strength Index (RSI)
  • OVID 30.65
  • KPLT 61.69
  • Support Level
  • OVID $0.50
  • KPLT $10.70
  • Resistance Level
  • OVID $0.58
  • KPLT $12.00
  • Average True Range (ATR)
  • OVID 0.06
  • KPLT 0.76
  • MACD
  • OVID 0.00
  • KPLT 0.02
  • Stochastic Oscillator
  • OVID 13.30
  • KPLT 79.66

About OVID Ovid Therapeutics Inc.

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential in-class mechanism of action.

About KPLT Katapult Holdings Inc.

Katapult Holdings Inc. is a technology-driven lease-to-own platform that integrates with omni-channel retailers and e-commerce platforms to power the purchase of everyday durable goods for underserved U.S. non-prime consumers. It is an e-commerce-focused FinTech company offering a lease-purchase solution to consumers and enabling essential transactions at the merchant point of sale. Katapult is associated with hundreds of retailers across the United States.

Share on Social Networks: